PBAC approves long-acting injectable PrEP for HIV
Patients with contraindications to daily oral HIV pre-exposure prophylaxis could soon access a PBS-subsidised long-acting injectable. Following its September meeting, the PBAC has recommended a…
Tag: PrEP
Aus success story: PrEP suppresses HIV incidence
Landmark study shows need for better access to PrEP in MSM living outside of 'urban gay areas', Professor Andrew Grulich says.
Reducing HIV in overseas-born MSM
A student returns from a visit to family in Vietnam with a fever and widespread rash.
Why is PrEP less effective in women?
Efficacy rates for the therapy for women vary wildly from -49-75%.
PrEP eclipses condoms for HIV prevention: study
The drug combination is now the most common strategy among Australian gay and bisexual men.
First case of HIV patient in long-term remission after drug therapy
The 'very interesting' case was reported at the AIDS 2020 conference.
PrEP users experience less HIV-related anxiety: Australian study
This benefit should be used to promote the drug among eligible men, researcher says.
A confession reveals the cause of debilitating knee pain
Julian, 32, presents with a painful left knee that he can’t explain. When his partner leaves the exam room, he reveals something that might help …
Almost twice as many men need to be on PrEP to stymie HIV
The good news is that new diagnoses have hit an 18-year low: latest report.
Early uptake of HIV treatment triples in a decade
Study on ART follows news of the seventh reported case of HIV transmission in a patient taking PrEP.
